Reports
Sale
Global Nicotine Replacement Therapy Market Size, Growth, Trends, Statistics, Forecast: By Product Type: Patches, Gums, Lozenges, Inhalers, Nasal Spray, Sublingual Tablets; By End User: Hospitals, Specialty Clinics, Homecare, Others; Regional Analysis; Patent Analysis; Grants Analysis; Clinical Trials Analysis; Supplier Landscape; 2024-2032
Global Nicotine Replacement Therapy Market Outlook
The global nicotine replacement therapy market size was valued at USD 3.09 billion in 2023, driven by the growing prevalence of health-related issues associated with cigarette smoking and the development of innovative nicotine gums. The market is anticipated to grow at a CAGR of 9.3% during the forecast period 2024-2032 to reach a value of USD 6.85 billion by 2032.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Rising Awareness Regarding the Health-Related Issues of Cigarettes Aiding the Market for Nicotine Replacement Therapy
The market for nicotine replacement therapy is being aided by the rising prevalence of health-related issues associated with cigarette smoking. Moreover, the increasing cardiovascular diseases related to nicotine consumption is surging the demand for nicotine replacement therapy. The growing use of nicotine chewing gum as a substitute for oral nicotine activities is driving the market for nicotine replacement therapy. As the awareness regarding the harmful effects of nicotine is increasing the demand for nicotine replacement therapy, the market is witnessing robust growth.
The increasing innovations to develop nicotine gums with enhanced taste is significantly contributing to the growth of the market. The growing use of nicotine gums to regulate and control nicotine intake is propelling the growth of the market. Moreover, the development of nicotine gums with innovative flavours like cinnamon, mint, and fruit, among others, to enhance their sensory appeal is positively impacting the market growth of nicotine replacement therapy.
Nicotine Replacement Therapy: Market Segmentation
Nicotine replacement therapy is a treatment that aids people quit the consumption of tobacco and nicotine. The products used in nicotine replacement therapy do not contain harmful toxins found in tobacco. As the sudden halt of nicotine intake leads to withdrawal symptoms, nicotine replacement therapy is used to reduce such symptoms.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The major products of nicotine replacement therapy are:
- Nicotine Replacement Therapy (NRT)
- E-cigarettes
- Heat-not-burn Tobacco Products
Nicotine replacement therapy (NRT) is further divided into inhalers, gum, transdermal patches, sublingual tablets, and lozenges, among others.
The market can be broadly categorised on the basis of its distribution channels into:
- Offline
- Online
The EMR report looks into the regional markets of nicotine replacement therapy like North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Increasing Use of E-Cigarettes as a Nicotine Replacement Therapy to Drive the Market Growth
As e-cigarettes do not expose smokers to harmful gases, they do not result in health-related issues as compared to traditional cigarettes. This is surging their use as a nicotine replacement therapy, especially in developed countries, which is propelling the growth of the market. In addition, the availability of diverse devices for vaping is providing a personalised smoking experience to cigarette smokers to aid them in quitting, which is significantly contributing to the market for nicotine replacement therapy.
The development of innovative e-cigarettes that meet public health standards is expected to drive the market growth. The increasing approval of sales and marketing of e-cigarettes by health authorities to reduce the dependency on traditional cigarettes is anticipated to fuel the market growth of the nicotine replacement therapy. For instance, in October 2021, the Food and Drug Administration (FDA) of the United States approved the sale and marketing of the e-cigarettes brand, Vuse, for the first time. Furthermore, the initiation of various research and development (R&D) activities to determine the effectiveness of e-cigarette as a nicotine replacement therapy is projected to propel the market growth in the forecast period.
Key Industry Players in the Global Nicotine Replacement Therapy Market
The report presents a detailed analysis of the following key players in the global nicotine replacement therapy market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
- Pfizer Inc.
- GlaxoSmithKline plc
- Novartis AG
- Mylan N.V.
- Teva Pharmaceutical Industries Ltd.
- Sanofi
- AstraZeneca
- Johnson & Johnson
- Merck & Co.
- Cipla
- Others
The comprehensive report looks into the macro and micro aspects of the industry. The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
|---|---|
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Product Type |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Nicotine Replacement Therapy Market Overview
3.1 Nicotine Replacement Therapy Market Historical Value (2017-2023)
3.2 Nicotine Replacement Therapy Market Forecast Value (2024-2032)
4 Global Nicotine Replacement Therapy Market Landscape
4.1 Nicotine Replacement Therapy: Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Nicotine Replacement Therapy: Product Landscape
4.2.1 Analysis by Product Type
4.2.2 Analysis by End user
5 Global Nicotine Replacement Therapy Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Nicotine Replacement Therapy Market Segmentation
6.1 Nicotine Replacement Therapy Market by Product Type
6.1.1 Market Overview
6.1.2 Patches
6.1.3 Gums
6.1.4 Lozenges
6.1.5 Inhalers
6.1.6 Nasal Spray
6.1.7 Sublingual Tablets
6.2 Nicotine Replacement Therapy Market by End User
6.2.1 Market Overview
6.2.2 Hospitals
6.2.3 Specialty Clinics
6.2.4 Homecare
6.2.5 Others
6.3 Nicotine Replacement Therapy Market by Region
6.3.1 Market Overview
6.3.2 North America
6.3.3 Europe
6.3.4 Asia Pacific
6.3.5 Latin America
6.3.6 Middle East and Africa
7 North America Nicotine Replacement Therapy
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Nicotine Replacement Therapy
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Nicotine Replacement Therapy
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Nicotine Replacement Therapy
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Nicotine Replacement Therapy
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Regulatory Framework
12.1 Regulatory Overview
12.1.1 US FDA
12.1.2 EU EMA
12.1.3 INDIA CDSCO
12.1.4 JAPAN PMDA
12.1.5 Others
13 Patent Analysis
13.1 Analysis by Type of Patent
13.2 Analysis by Publication year
13.3 Analysis by Issuing Authority
13.4 Analysis by Patent Age
13.5 Analysis by CPC Analysis
13.6 Analysis by Patent Valuation
13.7 Analysis by Key Players
14 Grants Analysis
14.1 Analysis by year
14.2 Analysis by Amount Awarded
14.3 Analysis by Issuing Authority
14.4 Analysis by Grant Application
14.5 Analysis by Funding Institute
14.6 Analysis by NIH Departments
14.7 Analysis by Recipient Organization
15 Clinical Trials Analysis
15.1 Analysis by Trial Registration Year
15.2 Analysis by Trial Status
15.3 Analysis by Trial Phase
15.4 Analysis by Therapeutic Area
15.5 Analysis by Geography
16 Funding and Investment Analysis
16.1 Analysis by Funding Instances
16.2 Analysis by Type of Funding
16.3 Analysis by Funding Amount
16.4 Analysis by Leading Players
16.5 Analysis by Leading Investors
16.6 Analysis by Geography
17 Partnership and Collaborations Analysis
17.1 Analysis by Partnership Instances
17.2 Analysis by Type of Partnership
17.3 Analysis by Leading Players
17.4 Analysis by Geography
18 Supplier Landscape
18.1 Pfizer Inc.
18.1.1 Financial Analysis
18.1.2 Product Portfolio
18.1.3 Demographic Reach and Achievements
18.1.4 Mergers and Acquisitions
18.1.5 Certifications
18.2 GlaxoSmithKline plc
18.2.1 Financial Analysis
18.2.2 Product Portfolio
18.2.3 Demographic Reach and Achievements
18.2.4 Mergers and Acquisitions
18.2.5 Certifications
18.3 Novartis AG
18.3.1 Financial Analysis
18.3.2 Product Portfolio
18.3.3 Demographic Reach and Achievements
18.3.4 Mergers and Acquisitions
18.3.5 Certifications
18.4 Mylan N.V.
18.4.1 Financial Analysis
18.4.2 Product Portfolio
18.4.3 Demographic Reach and Achievements
18.4.4 Mergers and Acquisitions
18.4.5 Certifications
18.5 Teva Pharmaceutical Industries Ltd.
18.5.1 Financial Analysis
18.5.2 Product Portfolio
18.5.3 Demographic Reach and Achievements
18.5.4 Mergers and Acquisitions
18.5.5 Certifications
18.6 Sanofi
18.6.1 Financial Analysis
18.6.2 Product Portfolio
18.6.3 Demographic Reach and Achievements
18.6.4 Mergers and Acquisitions
18.6.5 Certifications
18.7 AstraZeneca
18.7.1 Financial Analysis
18.7.2 Product Portfolio
18.7.3 Demographic Reach and Achievements
18.7.4 Mergers and Acquisitions
18.7.5 Certifications
18.8 Johnson & Johnson
18.8.1 Financial Analysis
18.8.2 Product Portfolio
18.8.3 Demographic Reach and Achievements
18.8.4 Mergers and Acquisitions
18.8.5 Certifications
18.9 Merck & Co.
18.9.1 Financial Analysis
18.9.2 Product Portfolio
18.9.3 Demographic Reach and Achievements
18.9.4 Mergers and Acquisitions
18.9.5 Certifications
18.10 Cipla
18.10.1 Financial Analysis
18.10.2 Product Portfolio
18.10.3 Demographic Reach and Achievements
18.10.4 Mergers and Acquisitions
18.10.5 Certifications
19 Nicotine Replacement Therapy - Distribution Model (Additional Insight)
19.1 Overview
19.2 Potential Distributors
19.3 Key Parameters for Distribution Partner Assessment
20 Key Opinion Leaders (KOL) Insights (Additional Insight)
21 Company Competitiveness Analysis (Additional Insight)
21.1 Very Small Companies
21.2 Small Companies
21.3 Mid-Sized Companies
21.4 Large Companies
21.5 Very Large Companies
22 Payment Methods (Additional Insight)
22.1 Government Funded
22.2 Private Insurance
22.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
Key Questions Answered in the Report
The global nicotine replacement therapy market reached a value of USD 3.09 billion in 2023.
The market is anticipated to grow at a CAGR of 9.3% during the forecast period of 2024-2032 to reach a value of USD 6.85 billion by 2032.
The market is being aided by the growing prevalence of health-related issues associated with cigarette smoking and the development of innovative nicotine gums.
The industry is expected to be augmented by the growing use of e-cigarettes, the availability of diverse devices for vaping, and the increasing approvals of e-cigarettes.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
The major products of nicotine replacement therapy in the industry are nicotine replacement therapy (NRT), e-cigarettes, and heat-not-burn tobacco products.
The significant distribution channels in the market are online and offline.
The major players in the industry are Pfizer Inc., GlaxoSmithKline plc, Novartis AG, Mylan N.V., Teva Pharmaceutical Industries Ltd., Sanofi, AstraZeneca, Johnson & Johnson, Merck & Co., and Cipla, among others.
Purchase Options
Call us on
Purchase Full Report
Mini Report
$ 3499
$1999
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 5999
$2999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 7999
$3999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 9999
$5999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER